196 related articles for article (PubMed ID: 20637759)
1. TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity.
Du J; Wu Z; Ren S; Wei Y; Gao M; Randolph GJ; Qu C
Vaccine; 2010 Aug; 28(38):6273-81. PubMed ID: 20637759
[TBL] [Abstract][Full Text] [Related]
2. Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic mice.
Wang Y; Chen K; Wu Z; Liu Y; Liu S; Zou Z; Chen SH; Qu C
Int J Infect Dis; 2014 Dec; 29():31-6. PubMed ID: 25449231
[TBL] [Abstract][Full Text] [Related]
3. Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075.
Spranger S; Javorovic M; Bürdek M; Wilde S; Mosetter B; Tippmer S; Bigalke I; Geiger C; Schendel DJ; Frankenberger B
J Immunol; 2010 Jul; 185(1):738-47. PubMed ID: 20511554
[TBL] [Abstract][Full Text] [Related]
4. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
[TBL] [Abstract][Full Text] [Related]
5. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
[TBL] [Abstract][Full Text] [Related]
6. The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.
Dowling DJ; Tan Z; Prokopowicz ZM; Palmer CD; Matthews MA; Dietsch GN; Hershberg RM; Levy O
PLoS One; 2013; 8(3):e58164. PubMed ID: 23483986
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
[TBL] [Abstract][Full Text] [Related]
8. The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes.
Ganapathi L; Van Haren S; Dowling DJ; Bergelson I; Shukla NM; Malladi SS; Balakrishna R; Tanji H; Ohto U; Shimizu T; David SA; Levy O
PLoS One; 2015; 10(8):e0134640. PubMed ID: 26274907
[TBL] [Abstract][Full Text] [Related]
9. Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.
Philbin VJ; Dowling DJ; Gallington LC; Cortés G; Tan Z; Suter EE; Chi KW; Shuckett A; Stoler-Barak L; Tomai M; Miller RL; Mansfield K; Levy O
J Allergy Clin Immunol; 2012 Jul; 130(1):195-204.e9. PubMed ID: 22521247
[TBL] [Abstract][Full Text] [Related]
10. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
11. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
[TBL] [Abstract][Full Text] [Related]
12. Accessory-cell-mediated activation of porcine NK cells by toll-like receptor 7 (TLR7) and TLR8 agonists.
Toka FN; Nfon CK; Dawson H; Golde WT
Clin Vaccine Immunol; 2009 Jun; 16(6):866-78. PubMed ID: 19369481
[TBL] [Abstract][Full Text] [Related]
13. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
14. The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice.
Ma F; Zhang J; Zhang J; Zhang C
Cell Mol Immunol; 2010 Sep; 7(5):381-8. PubMed ID: 20543857
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies.
Lan T; Dai M; Wang D; Zhu FG; Kandimalla ER; Agrawal S
J Med Chem; 2009 Nov; 52(21):6871-9. PubMed ID: 19824640
[TBL] [Abstract][Full Text] [Related]
17. Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model.
Ma Y; Poisson L; Sanchez-Schmitz G; Pawar S; Qu C; Randolph GJ; Warren WL; Mishkin EM; Higbee RG
Immunology; 2010 Jul; 130(3):374-87. PubMed ID: 20331478
[TBL] [Abstract][Full Text] [Related]
18. Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy.
Kim H; Niu L; Larson P; Kucaba TA; Murphy KA; James BR; Ferguson DM; Griffith TS; Panyam J
Biomaterials; 2018 May; 164():38-53. PubMed ID: 29482062
[TBL] [Abstract][Full Text] [Related]
19. Evidence of regulatory myeloid dendritic cells and circulating inflammatory epidermal dendritic cells-like modulated by Toll-like receptors 2 and 7/8 in adults with atopic dermatitis.
Dos Santos VG; Orfali RL; de Oliveira Titz T; da Silva Duarte AJ; Sato MN; Aoki V
Int J Dermatol; 2017 Jun; 56(6):630-635. PubMed ID: 28083892
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands.
Martinson JA; Roman-Gonzalez A; Tenorio AR; Montoya CJ; Gichinga CN; Rugeles MT; Tomai M; Krieg AM; Ghanekar S; Baum LL; Landay AL
Cell Immunol; 2007; 250(1-2):75-84. PubMed ID: 18334250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
